Joint Research on an Early Diagnosis System for Autoimmune and Chronic Inflammatory Diseases
First written in FY2019-Q1. 1 of 2 entries say "Restated". Latest entry: FY2019-Q2.
No other company in this theme has enough history to compare yet.
- FY2019-Q2RestatedAnnual report
「In June 2018, the company, the Foundation for Kobe Biomedical Innovation and Kyoto University began joint research under the “Drug Discovery Innovation Program—Development of Diagnostic Technology for Immune-Related Diseases—” promoted by the Foundation for Kobe Biomedical Innovation. Through the joint research, the 3 parties aim to create a diagnostic system enabling the early detection of autoimmune and chronic inflammatory diseases.」
Restates the joint research with the Foundation for Kobe Biomedical Innovation and Kyoto University and the policy of creating a diagnostic system enabling the early detection of autoimmune and chronic inflammatory diseases. - FY2019-Q1First statedAnnual report
「In June 2018, the company, the Foundation for Kobe Biomedical Innovation and Kyoto University began joint research under the “Drug Discovery Innovation Program—Development of Diagnostic Technology for Immune-Related Diseases—” promoted by the Foundation for Kobe Biomedical Innovation. Through the joint research, the 3 parties aim to create a diagnostic system enabling the early detection of autoimmune and chronic inflammatory diseases.」
Began joint research with the Foundation for Kobe Biomedical Innovation and Kyoto University, aiming to create a diagnostic system enabling the early detection of autoimmune and chronic inflammatory diseases.